Role of interim PET/CT as predictor of outcome in newly diagnosed diffuse large b-cell lymphoma in the chemo-immunotherapy era - 15/10/23
Doi : 10.1016/j.retram.2023.103406
Moussab Damlaj a, b, c, d, e, ⁎ 
, Waed Jaber a, Afnan Al Najjar c, Sumayyah Altamimi c, Tarfa Al Onazi c, Mohammed Alzayed d, e, f, Ahmad Damlaj g, Rehab Yassin c, d, e, Bader Alahmari c, d, e, Ayman Alhejazi c, d, e, Giamal Gmati c, d, e, Khadega Abuelgasim c, f, e, Hind Salama c, d, e, Ahmed Alaskar c, d, e, Mohsen Al Zahrani c, d, e
, Waed Jaber a, Afnan Al Najjar c, Sumayyah Altamimi c, Tarfa Al Onazi c, Mohammed Alzayed d, e, f, Ahmad Damlaj g, Rehab Yassin c, d, e, Bader Alahmari c, d, e, Ayman Alhejazi c, d, e, Giamal Gmati c, d, e, Khadega Abuelgasim c, f, e, Hind Salama c, d, e, Ahmed Alaskar c, d, e, Mohsen Al Zahrani c, d, e a Division of Hematology & Oncology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE
b Khalifa University, College of Medicine, Abu Dhabi, UAE
c Department of Oncology, King Abdulaziz Medical City, Riyadh, KSA
d King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA
e King Abdullah International Medical Research Center, Riyadh, KSA
f Department of Medical Imaging, King Abdulaziz Medical City, Riyadh, KSA
g American University of Beirut, Beirut, Lebanon
⁎Corresponding author at: Division of Hematology & Oncology, Sheikh Shakhbout Medical City, Abu Dhabi, UAE.Division of Hematology & OncologySheikh Shakhbout Medical CityAbu DhabiUAE
Le texte complet de cet article est disponible en PDF.
Plan
© 2023
Elsevier Masson SAS. Tous droits réservés.
Vol 71 - N° 3
Article 103406- juillet 2023 Retour au numéro
Article précédent
- Coexistence of three hematological malignancies in association with a first time documented mutation: “One train can hide another”°, and even more!
- Tamim Alsuliman, Souhila Ikhlef, Nicolas Stocker, Fazia Kaoui, Laure Ricard, Malek Aoudjhane, Mohamad Mohty, Zora Marjanovic
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?